RXRX icon

Recursion Pharmaceuticals

247 hedge funds and large institutions have $2.12B invested in Recursion Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 88 increasing their positions, 53 reducing their positions, and 18 closing their positions.

Holders
247
Holders Change
+49
Holders Change %
+24.75%
% of All Funds
3.58%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
68
Increased
88
Reduced
53
Closed
18
Calls
$15.6M
Puts
$21.4M
Net Calls
-$5.86M
Net Calls Change
-$10.4M
Name Market Value Shares Shares
Change
Shares
Change %
FA
251
FDx Advisors
Illinois
-23,299 Closed
SG Americas Securities
252
SG Americas Securities
New York
-22,186 Closed
GWM
253
GoalFusion Wealth Management
Texas
-20,000 Closed
PCM
254
Prelude Capital Management
New York
-19,733 Closed
XT
255
XTX Topco
Cayman Islands
-15,349 Closed
GIA
256
Gladstone Institutional Advisory
Florida
-13,492 Closed
GCP
257
GSA Capital Partners
United Kingdom
-10,860 Closed
EOJOAM
258
E. Ohman J:or Asset Management
Sweden
-7,482 Closed
IUHSA
259
Itau Unibanco Holding S.A.
Brazil
-3,161 Closed
TWM
260
Tradition Wealth Management
Minnesota
-1,584 Closed
ODG
261
O'Dell Group
Ohio
-1,200 Closed
ASN
262
Advisory Services Network
Georgia
-1,110 Closed
NMG
263
New Millennium Group
Utah
-275 Closed
ACA
264
American Capital Advisory
Idaho
-200 Closed
C
265
Covestor
United Kingdom
$0 13 -1 -7%
Group One Trading
266
Group One Trading
Illinois
SPM
267
Symmetry Peak Management
Pennsylvania
CG
268
Cutler Group
California
CM
269
Caption Management
Oklahoma
CFGS
270
Concourse Financial Group Securities
Alabama